Log in
|
Specification |
Details |
|
Drug Detected |
Flakka (α-PVP / Alpha-Pyrrolidinovalerophenone) |
|
Cutoff Level |
500 ng/mL |
|
Sample Type |
Human Urine |
|
Test Format |
Dip Test Strip |
|
Time to Results |
Approximately 5 Minutes |
|
Intended Use |
Professional & Forensic Use Only |
Using the test strip is quick and straightforward:
Remove the test strip from its sealed pouch and use it promptly.
Hold the strip by the labeled end only and avoid touching the test membrane.
Dip the strip vertically into the urine specimen for 10–15 seconds, ensuring the urine level does not exceed the MAX line.
Remove the strip and place it on a clean, dry, non-absorbent surface.
Read the results within 3–5 minutes.
Do not interpret results after 10 minutes.
Always follow the testing instructions carefully to ensure accurate specimen collection and reliable result interpretation
The Flakka (α-PVP) Test Strips are suitable for:
Workplace drug testing
Clinical laboratories
Substance abuse treatment programs
Rehabilitation centers
Occupational health clinics
Law enforcement agencies
Forensic laboratories
Correctional facilities
Professional drug screening programs
Flakka, also known as Alpha-Pyrrolidinovalerophenone (α-PVP), is a synthetic stimulant belonging to the synthetic cathinone family, a group of substances commonly referred to as "bath salts." It acts on the central nervous system and is known for its powerful stimulant effects.
Flakka is an illicit substance with a high potential for misuse and abuse. Because of its unpredictable effects and associated health risks, it is frequently included in professional drug screening and forensic testing programs
Flakka testing is important for identifying recent use of α-PVP in situations where synthetic stimulant abuse may be suspected. Rapid screening supports timely decision-making in workplace, clinical, rehabilitation, and forensic settings.
The Flakka Test Strip provides a quick and reliable method for preliminary urine screening, allowing organizations to identify possible exposure while reducing turnaround time compared with laboratory-only testing
Flakka use may produce a range of stimulant effects, including:
Increased energy
Elevated heart rate
Agitation
Anxiety
Restlessness
Insomnia
Confusion
Aggressive behavior
Hallucinations
Paranoia
Severe intoxication may lead to dangerous medical complications requiring immediate professional attention.
The Flakka (α-PVP) Test Strip (500 ng/mL) offers several benefits for professional drug screening:
Detects Flakka (α-PVP) in human urine
500 ng/mL cutoff for reliable preliminary screening
Rapid results in approximately 5 minutes
High accuracy and sensitivity
Simple dip-and-read testing procedure
No specialized laboratory equipment required
Easy interpretation of results
Suitable for routine and high-volume testing
Reliable performance for professional drug screening programs
The Flakka (α-PVP) Test Strip (500 ng/mL) offers a fast, accurate, and convenient solution for detecting α-PVP in human urine. With its 5-minute results, 500 ng/mL cutoff level, and simple dip-and-read format, it enables efficient preliminary screening in professional environments where rapid and dependable drug testing is essential.
Its ease of use, reliable performance, and suitability for routine or high-volume testing make it an excellent choice for clinical laboratories, workplace testing programs, rehabilitation facilities, law enforcement agencies, and forensic investigations.
For best performance:
Store the test strips according to the recommended storage conditions.
Keep each strip sealed in its original pouch until ready for use.
Use the strip immediately after opening the pouch.
Do not use the product beyond its expiration date.
Protect the test from excessive heat, moisture, and direct sunlight.
Handle urine specimens using appropriate laboratory safety procedures
The Flakka (α-PVP) Test Strip (500 ng/mL) is intended to provide preliminary qualitative screening results only.
A positive result indicates the possible presence of Flakka (α-PVP) above the screening cutoff but does not determine the amount used, the time of use, or the level of impairment.
A negative result does not completely exclude drug use if the concentration is below the cutoff level or outside the detection window.
Individual metabolism, specimen quality, and testing procedures may influence results.
All preliminary positive results should be confirmed using GC-MS or LC-MS/MS before legal, employment, or administrative decisions are made
The test detects Flakka (Alpha-Pyrrolidinovalerophenone / α-PVP) in human urine at a 500 ng/mL cutoff level.
Results are available in approximately 5 minutes when the test is performed according to the instructions.
No. This product is intended for professional and forensic screening only and is not intended for medical diagnosis or home use.
No. This is a screening test only. Any preliminary positive result should be confirmed using GC-MS or LC-MS/MS before medical, legal, employment, or administrative decisions are made.
The Flakka Test Strip is intended for clinical laboratories, workplace drug testing programs, rehabilitation centers, occupational health providers, forensic laboratories, law enforcement agencies, correctional facilities, and other professional drug screening environments
The Flakka (α-PVP) Test Strip (500 ng/mL) provides a fast, accurate, and easy-to-use solution for the preliminary detection of Flakka (Alpha-Pyrrolidinovalerophenone / α-PVP) in human urine. Featuring a 500 ng/mL cutoff level, convenient dip-and-read format, and results in approximately 5 minutes, it is an effective choice for professional drug screening programs.
Designed for use in workplace testing, clinical laboratories, rehabilitation centers, law enforcement agencies, correctional facilities, and forensic investigations, the test delivers dependable preliminary results without the need for specialized laboratory equipment. Its rapid turnaround time, simple testing procedure, and reliable performance make it well suited for both routine and high-volume screening applications.
As with all rapid immunoassay drug screening devices, any preliminary positive result should be confirmed using Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, employment, or administrative decisions are made. The Flakka (α-PVP) Test Strip (500 ng/mL) is intended for professional and forensic use only and is not intended for medical diagnosis or home testing.
The Flakka (α-PVP) Test Strips are rapid urine screening devices designed for the qualitative detection of Flakka (Alpha-Pyrrolidinovalerophenone, α-PVP) in human urine. Featuring a 500 ng/mL cutoff level, these easy-to-use dip-and-read test strips provide reliable preliminary screening results in approximately 5 minutes.
Flakka is a synthetic cathinone and a member of the group commonly referred to as "bath salts." Due to its powerful stimulant properties and potential for abuse, rapid detection is important in professional drug screening, forensic investigations, workplace testing, and substance abuse monitoring.
The test strip requires only a urine specimen and does not require specialized laboratory equipment or extensive operator training. Its straightforward testing procedure makes it suitable for both routine and high-volume drug screening programs.
Designed with high sensitivity and built-in procedural controls, the Flakka Test Strip provides dependable preliminary screening while supporting efficient decision-making in clinical, forensic, and occupational testing environments.
This test provides preliminary qualitative screening results only. Any preliminary positive result should be confirmed using an appropriate laboratory confirmation method such as Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, employment, or administrative decisions are made.
The Flakka (α-PVP) Test Strip is intended for forensic and professional use only and is not intended for medical diagnosis or home testing.
Flakka (α-PVP / Alpha-Pyrrolidinovalerophenone)
Flakka (α-PVP) is generally detectable in urine for approximately 2–4 days after use. Detection times may vary depending on several factors, including:
Detection windows are approximate and should be interpreted by qualified professionals.
This Flakka Test Strip uses the following screening cutoff:
Flakka (α-PVP): 500 ng/mL
Samples at or above this concentration may produce a preliminary positive result and should be confirmed using an appropriate laboratory confirmation method
A colored line appears in both the Control (C) and Test (T) regions. Even if the Test (T) line is faint, the result should be interpreted as negative, indicating that the concentration of Flakka (α-PVP) is below the 500 ng/mL cutoff level.
A colored line appears only in the Control (C) region, while no visible line appears in the Test (T) region. This indicates that the concentration of Flakka (α-PVP) may be at or above the 500 ng/mL screening cutoff.
Because this test provides preliminary screening results only, all positive results should be confirmed using a more specific laboratory method such as Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, employment, or administrative decisions are made.
If the Control (C) line does not appear, the test is considered invalid, regardless of whether a Test line is visible. This may result from insufficient specimen volume, incorrect testing procedure, or a defective test strip.
Repeat the test using a new strip and a fresh urine specimen
Flakka (α-PVP) Test Strips 500 ng/mL | Serenity SM-DOA-FLAKSCN 25/Box
Sign up for updates from leading retailers
